COMBINATION ANTIARRHYTHMIC DRUG-THERAPY

被引：0
|
作者：
LUDERITZ, B
JUNG, W
MANZ, M
机构：
来源：
MEDIZINISCHE KLINIK | 1992年 / 87卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：465 / 468
页数：4
相关论文
共 50 条
  • [1] COMBINATION ANTIARRHYTHMIC DRUG-THERAPY FOR VENTRICULAR TACHYARRHYTHMIAS
    GREENSPAN, AM
    SPIELMAN, SR
    HOROWITZ, LN
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (04): : 565 - 576
  • [2] ADVANCES IN ANTIARRHYTHMIC DRUG-THERAPY
    LUDERITZ, B
    HERZ KREISLAUF, 1978, 10 (03): : 99 - 106
  • [3] NEW DIRECTIONS IN ANTIARRHYTHMIC DRUG-THERAPY
    SOMBERG, JC
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (04): : B8 - B17
  • [4] DRUG-THERAPY - RISKS AND BENEFITS OF ANTIARRHYTHMIC THERAPY
    RODEN, DM
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (12): : 785 - 791
  • [5] INDIVIDUAL OPTIMIZATION OF THE ANTIARRHYTHMIC DRUG-THERAPY
    ULM, K
    SCHMIDT, G
    CONTROLLED CLINICAL TRIALS, 1988, 9 (03): : 257 - 257
  • [6] WHAT REMAINS OF ANTIARRHYTHMIC DRUG-THERAPY
    LEVY, S
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1993, 86 (10): : 1501 - 1505
  • [7] ANTIARRHYTHMIC DRUG-THERAPY OF VENTRICULAR ARRHYTHMIAS
    HUANG, SK
    MARCUS, FI
    CURRENT PROBLEMS IN CARDIOLOGY, 1986, 11 (04) : 179 - 240
  • [8] PHARMACOKINETIC DRUG-INTERACTIONS IN ANTIARRHYTHMIC DRUG-THERAPY
    HORI, R
    OKUMURA, K
    YASUHARA, M
    PHARMACY INTERNATIONAL, 1985, 6 (02): : 37 - 40
  • [9] IS PRETRANSPLANT ANTIARRHYTHMIC DRUG-THERAPY A RISK FACTOR
    KONERTZ, W
    WEYAND, M
    DEIWICK, M
    SCHELD, HH
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (06) : 2677 - 2678
  • [10] ANTIARRHYTHMIC DRUG-THERAPY OF CHRONIC VENTRICULAR ARRHYTHMIAS
    MOTTE, G
    SLAMA, M
    DINANIAN, S
    SEBAG, C
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1992, 85 : 85 - 89
12345